查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1679371

雾化器市场规模、份额、趋势分析报告：按类型、应用、最终用途、地区和细分市场预测，2025 年至 2030 年

Nebulizer Market Size, Share & Trends Analysis Report By Type (Jet, Mesh, Ultrasonic), By Application (COPD, Asthma, Cystic Fibrosis), By End-use (Hospitals & Clinics, Emergency Centers, Home Healthcare), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

雾化器市场的成长与趋势

根据 Grand View Research, Inc. 的最新报告，全球雾化器市场规模预计到 2030 年将达到 17.7 亿美元，2025 年至 2030 年的复合年增长率为 6.35%。

慢性呼吸系统疾病盛行率上升、居家医疗设备需求增加以及全球老龄人口成长是推动市场成长的主要因素。

COVID-19 疫情已影响全球数百万人。患有气喘和慢性阻塞性肺病 (COPD) 的患者意识到 COVID-19 透过空气传播的风险，因此不愿使用吸入药物，因为吸入药物被认为可能会增加病毒传播并抑制免疫系统。然而，全科医生鼓励所有此类患者继续使用复方吸入药物，包括雾化器。在美国某些地区，当药局面临吸入性沙丁胺醇短缺时，建议使用雾化沙丁胺醇作为沙丁胺醇救援药物的替代品。

COVID-19 影响了许多老年人。根据美国肺臟协会 (ALA) 2020 年的报告，雾化治疗是 COVID-19 期间患者在家中治疗 COPD 的安全有效的方法。这反过来又推动了对雾化器的需求。

根据人口问题实验室的报告《美国的老化》，美国老年人口数量预计将从2016年的4,800万人增加到2060年的9,800万人。老年人更容易患慢性阻塞性肺病和睡眠呼吸中止症等呼吸系统疾病。因此，老年人口的增加有望扩大製造商的患者群并推动市场成长。

此外，由于网状雾化器能够精确地向肺部输送药物，且残留量较少，其商业性接受度不断提高，这也推动了市场的成长。此外，药物-设备组合等技术进步有望为雾化器市场创造新的机会。

然而，雾化过程中的药物损失是限制市场成长的主要因素。然而，这也可能为网状雾化器製造商带来机会，因为它们的製造目的是提供精确的药物剂量，同时最大限度地减少药物损失。

雾化器市场报告重点

  • 按类型划分，喷射雾化器部分占据 2024 年最大收入份额，为 64.82%。
  • 由于技术先进的紧凑型设备以及最少的药物损失，预计网状雾化器类型部分在预测期内将表现出良好的复合年增长率。
  • 按应用划分，慢性阻塞性肺病(COPD) 领域在 2024 年占据了最大的市场占有率。这是由于 COPD 在世界各地的盛行率很高，而且最近的技术进步使得雾化器更加便携且易于使用。
  • 2024年，医院部门占最大收益占有率，为67.25%。这是由于优惠的报销政策和大量的患者客流量。
  • 2024 年，北美占了最大的收益占有率，为 34.06%。气喘、慢性阻塞性肺病(COPD) 和支气管炎等呼吸系统疾病很普遍，推动了市场的成长。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章雾化器市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 雾化器市场分析工具
    • 产业分析—波特五力分析
    • PESTEL 分析
    • 法律规范
    • 新兴科技趋势
    • COVID-19影响分析

第 4 章 雾化器市场：按类型进行估计和趋势分析

  • 细分仪表板
  • 全球雾化器市场类型变化分析
  • 2018 年至 2030 年全球雾化器市场规模及趋势分析（按类型）
  • 喷射雾化器
  • 网状雾化器
    • 主动网状雾化器
    • 被动式网状雾化器
  • 超音波雾化器

第五章 雾化器市场：按应用的估计和趋势分析

  • 细分仪表板
  • 全球雾化器市场应用变化分析
  • 2018-2030 年全球雾化器市场规模及应用趋势分析
  • 慢性阻塞性肺病
  • 囊肿纤维化
  • 气喘
  • 其他的

第 6 章雾化器市场：最终用途、估计与趋势分析

  • 细分仪表板
  • 全球雾化器市场最终用途趋势分析
  • 2018-2030年全球雾化器市场规模及趋势分析（依最终用途）
  • 医院和诊所
  • 急诊中心
  • 居家医疗

第七章雾化器市场：区域、估计和趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章竞争格局

  • 公司/竞争对手分类
  • 战略地图
  • 2024 年公司市场占有率/地位分析
  • 公司简介/上市公司
    • OMRON Corporation
    • GE Healthcare
    • Koninklijke Philips NV
    • Vectura Group Plc.
    • PARI Respiratory Equipment, Inc.
    • Aerogen
    • DeVilbiss Healthcare LLC
    • Beurer GmBH
    • Microlife Corporation
    • GF Health Products, Inc.
    • Rossmax International Ltd.
    • BESCO MEDICAL LIMITED
    • Bremed Ltd.
Product Code: GVR-2-68038-069-9

Nebulizer Market Growth & Trends:

The global nebulizer market size is estimated to reach USD 1.77 billion by 2030, registering a CAGR of 6.35% from 2025 to 2030, according to a new report by Grand View Research, Inc., Rising incidence rate of chronic respiratory diseases, increasing demand for home healthcare devices, and rising geriatric population worldwide are the major factors leading to the market growth.

The COVID-19 outbreak has affected millions of people around the globe. Asthma or COPD patients, who were aware regarding the risk of airborne transmission of COVID-19, were hesitant with regard to the use of inhaled medications, which are considered as a potential source of viral transmission and immunosuppression. Though, medical practitioners advised all such patients to continue using their prescribed inhaled medications, including nebulizers. Nebulized albuterol was recommended in some parts of the U.S. as an alternative to albuterol rescue inhalers when pharmacies faced shortage of albuterol inhalers.

COVID-19 affects many elderly people. According to the American Lung Association (ALA) in 2020, nebulized therapy is a safe and effective way to manage COPD at home for patients during COVID-19. Consequently, promotes the nebulizers demand.

According to the Population Reference Bureau report, "Aging in the United States", the geriatric population in U.S. is estimated to increase from 48 million in 2016 to 98 million by 2060. Elderly people are susceptible to respiratory diseases such as COPD and sleep apnea. Therefore, growing geriatric population is expected to expand the patient pool for manufacturers and propel the growth of the market.

Increasing commercial acceptance of mesh nebulizers due to accurate delivery of drug to the lung and lower residual volumes also aids in market growth. Furthermore, Technological advancements such as drug-device combination is further expected to create newer opportunity in the nebulizer market.

On the other hand, drug loss during nebulization is the major factor restraining the market growth. However, this can also act as an opportunity for the mesh nebulizer manufacturers as the devices are manufactured to deliver accurate drug dosage while reduce drug loss.

Nebulizer Market Report Highlights:

  • By type, the jet nebulizers segment held the largest revenue share of 64.82% in 2024, owing to the low cost of the devices.
  • Mesh nebulizers type segment is expected to witness lucrative CAGR over the forecast period, due to the technologically advanced compact size devices and minimized drug loss.
  • Based on application, the chronic obstructive pulmonary disorder (COPD) segment accounted for the largest market share in 2024, owing to the high global prevalence of COPD, recent technological advancements have made nebulizers more portable and user-friendly.
  • In 2024, the hospitals segment accounted for the largest revenue share of 67.25% in 2024, owing to the favorable reimbursement policies and significant patient footfall.
  • North America held the largest revenue share of 34.06% in 2024. Respiratory diseases such as asthma, Chronic Obstructive Pulmonary Disease (COPD), and bronchitis have become more prevalent, thereby contributing to market growth.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Type Segment
    • 1.2.2. Application Segment
    • 1.2.3. End Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Nebulizers Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of chronic respiratory diseases
      • 3.2.1.2. Growing demand for home healthcare products
      • 3.2.1.3. Increasing availability of advanced and cost-effective technologies
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Drug loss during drug delivery
      • 3.2.2.2. Risk of disease transmission
      • 3.2.2.3. Stringent regulatory requirements
  • 3.3. Nebulizers Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
      • 3.3.2.4. Environmental Landscape
      • 3.3.2.5. Legal Landscape
      • 3.3.2.6. Social Landscape
    • 3.3.3. Regulatory Framework
    • 3.3.4. Emerging Technology Trends
    • 3.3.5. COVID-19 Impact Analysis

Chapter 4. Nebulizers Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Nebulizers Market Type Movement Analysis
  • 4.3. Global Nebulizers Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Jet Nebulizer
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Mesh Nebulizer
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Active Mesh Nebulizer
      • 4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Passive Mesh Nebulizer
      • 4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Ultrasonic Nebulizer
    • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Nebulizers Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Nebulizers Market Application Movement Analysis
  • 5.3. Global Nebulizers Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. COPD
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Cystic Fibrosis
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Asthma
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. ebulizers Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Nebulizers Market End Use Movement Analysis
  • 6.3. Global Nebulizers Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospital and Clinics
    • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Emergency Centers
    • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Home Healthcare
    • 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Nebulizers Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Norway
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive scenario
      • 7.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. South Africa
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share/Position Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. OMRON Corporation
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. GE Healthcare
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Koninklijke Philips N.V.
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Vectura Group Plc.
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. PARI Respiratory Equipment, Inc.
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Aerogen
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. DeVilbiss Healthcare LLC
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Beurer GmBH
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Microlife Corporation
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. GF Health Products, Inc.,
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives
    • 8.4.11. Rossmax International Ltd.
      • 8.4.11.1. Company overview
      • 8.4.11.2. Financial performance
      • 8.4.11.3. Product benchmarking
      • 8.4.11.4. Strategic initiatives
    • 8.4.12. BESCO MEDICAL LIMITED
      • 8.4.12.1. Company overview
      • 8.4.12.2. Financial performance
      • 8.4.12.3. Product benchmarking
      • 8.4.12.4. Strategic initiatives
    • 8.4.13. Bremed Ltd.
      • 8.4.13.1. Company overview
      • 8.4.13.2. Financial performance
      • 8.4.13.3. Product benchmarking
      • 8.4.13.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global nebulizers market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 4 Global nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 6 North America nebulizers market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 8 North America nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 9 North America nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S. nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 11 U.S. nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S. nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 14 Canada nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Mexico nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 17 Mexico nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 18 Mexico nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe nebulizers market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 21 Europe nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 23 UK nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 24 UK nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 25 UK nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Germany nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 27 Germany nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 28 Germany nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 29 France nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 30 France nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 31 France nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 33 Italy nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 34 Italy nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 36 Spain nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Denmark nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 39 Denmark nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 40 Denmark nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Sweden nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 42 Sweden nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 43 Sweden nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Norway nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 45 Norway nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 46 Norway nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific nebulizers market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 51 China nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 52 China nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 53 China nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Japan nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 55 Japan nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 56 Japan nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 57 India nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 58 India nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 59 India nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 60 South Korea nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 61 South Korea nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 62 South Korea nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 63 Australia nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 64 Australia nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 65 Australia nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Thailand nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 67 Thailand nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 68 Thailand nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Latin America nebulizers market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 71 Latin America nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 72 Latin America nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Brazil nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 74 Brazil nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 75 Brazil nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 77 Argentina nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 78 Argentina nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 79 MEA nebulizers market, by country, 2018 - 2030 (USD Million)
  • Table 80 MEA nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 81 MEA nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 82 MEA nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 83 South Africa nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 84 South Africa nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 85 South Africa nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 89 UAE nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 90 UAE nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 91 UAE nebulizers market, by end use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait nebulizers market, by type, 2018 - 2030 (USD Million)
  • Table 93 Kuwait nebulizers market, by application, 2018 - 2030 (USD Million)
  • Table 94 Kuwait nebulizers market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Nebulizers market: Market outlook
  • Fig. 5 Nebulizers market: Segment outlook
  • Fig. 6 Nebulizers market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Nebulizers market driver impact
  • Fig. 9 Nebulizers market restraint impact
  • Fig. 10 Nebulizers market: Type outlook and key takeaways
  • Fig. 11 Nebulizers market: Type movement analysis
  • Fig. 12 Jet nebulizers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 Mesh nebulizers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Active mesh nebulizers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Passive mesh nebulizers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Ultrasonic nebulizers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Nebulizers market: Application outlook and key takeaways
  • Fig. 18 Nebulizers market: Application movement analysis
  • Fig. 19 COPD market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Cystic fibrosis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Asthma market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Nebulizers market: End use outlook and key takeaways
  • Fig. 24 Nebulizers market: End use movement analysis
  • Fig. 25 Hospital and Clinics market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 26 Emergency Centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Home Healthcare market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 28 Global nebulizers market: Regional outlook and key takeaways
  • Fig. 29 Global nebulizers market: Regional movement analysis
  • Fig. 30 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Key country dynamics
  • Fig. 32 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Key country dynamics
  • Fig. 34 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Key country dynamics
  • Fig. 36 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Key country dynamics
  • Fig. 39 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)